In particular, we demonstrated that PAQR8 is both necessary and sufficient to promote efficient mammary tumor recurrence following Her2 inhibition and that PAQR8 facilitates the outgrowth of orthotopically implanted ER + tumor cells under conditions of estrogen deprivation. Here, ERBB2 is linked to neoplasm.